A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes
Clinical trial NCT03945656 · COMPLETED
Trial details
- NCT number
- NCT03945656
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2021-09-27
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.